115 related articles for article (PubMed ID: 16502953)
1. Cost utility analysis of physical activity counselling in general practice.
Dalziel K; Segal L; Elley CR
Aust N Z J Public Health; 2006 Feb; 30(1):57-63. PubMed ID: 16502953
[TBL] [Abstract][Full Text] [Related]
2. Is brief advice in primary care a cost-effective way to promote physical activity?
Anokye NK; Lord J; Fox-Rushby J
Br J Sports Med; 2014 Feb; 48(3):202-6. PubMed ID: 24352807
[TBL] [Abstract][Full Text] [Related]
3. Health benefits and costs of weight-loss dietary counselling by nurses in primary care: a cost-effectiveness analysis.
Cleghorn CL; Wilson N; Nair N; Kvizhinadze G; Nghiem N; McLeod M; Blakely T
Public Health Nutr; 2020 Jan; 23(1):83-93. PubMed ID: 31608841
[TBL] [Abstract][Full Text] [Related]
4. Cost effectiveness of imatinib compared with interferon-alpha or hydroxycarbamide for first-line treatment of chronic myeloid leukaemia.
Dalziel K; Round A; Garside R; Stein K
Pharmacoeconomics; 2005; 23(5):515-26. PubMed ID: 15896102
[TBL] [Abstract][Full Text] [Related]
5. Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin: systematic review and economic evaluation.
Simpson EL; Duenas A; Holmes MW; Papaioannou D; Chilcott J
Health Technol Assess; 2009 Mar; 13(17):iii, ix-x, 1-154. PubMed ID: 19331797
[TBL] [Abstract][Full Text] [Related]
6. Long-term cost-effectiveness of collaborative care (vs usual care) for people with depression and comorbid diabetes or cardiovascular disease: a Markov model informed by the COINCIDE randomised controlled trial.
Camacho EM; Ntais D; Coventry P; Bower P; Lovell K; Chew-Graham C; Baguley C; Gask L; Dickens C; Davies LM
BMJ Open; 2016 Oct; 6(10):e012514. PubMed ID: 27855101
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Cost-Effectiveness of Insulin Glargine Versus Neutral Protamine Hagedorn Insulin for Type 2 Diabetes in Thailand.
Permsuwan U; Chaiyakunapruk N; Dilokthornsakul P; Thavorn K; Saokaew S
Appl Health Econ Health Policy; 2016 Jun; 14(3):281-92. PubMed ID: 26961276
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of physical activity counselling in general practice.
Elley R; Kerse N; Arroll B; Swinburn B; Ashton T; Robinson E
N Z Med J; 2004 Dec; 117(1207):U1216. PubMed ID: 15608809
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of brief behavioral counselling by allied health professionals to promote physical activity in people with peripheral arterial disease (BIPP): study protocol for a multi-center randomized controlled trial.
Burton NW; Ademi Z; Best S; Fiatarone Singh MA; Jenkins JS; Lawson KD; Leicht AS; Mavros Y; Noble Y; Norman P; Norman R; Parmenter BJ; Pinchbeck J; Reid CM; Rowbotham SE; Yip L; Golledge J
BMC Public Health; 2016 Nov; 16(1):1148. PubMed ID: 27829449
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of alternative treatments for depression in low-income women.
Beil H; Beeber LS; Schwartz TA; Lewis G
J Ment Health Policy Econ; 2013 Jun; 16(2):55-65. PubMed ID: 23999203
[TBL] [Abstract][Full Text] [Related]
11. Cost effectiveness of pegaptanib for the treatment of age-related macular degeneration in the UK.
Wolowacz SE; Roskell N; Kelly S; Maciver FM; Brand CS
Pharmacoeconomics; 2007; 25(10):863-79. PubMed ID: 17887807
[TBL] [Abstract][Full Text] [Related]
12. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.
Haentjens P; De Groote K; Annemans L
Arch Orthop Trauma Surg; 2004 Oct; 124(8):507-17. PubMed ID: 15365714
[TBL] [Abstract][Full Text] [Related]
13. A systematic review and economic evaluation of exercise referral schemes in primary care: a short report.
Campbell F; Holmes M; Everson-Hock E; Davis S; Buckley Woods H; Anokye N; Tappenden P; Kaltenthaler E
Health Technol Assess; 2015 Jul; 19(60):1-110. PubMed ID: 26222987
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness analysis of offering free leisure centre memberships to physically inactive members of the public receiving state benefits: a case study.
Verhoef TI; Trend V; Kelly B; Robinson N; Fox P; Morris S
BMC Public Health; 2016 Jul; 16():616. PubMed ID: 27449787
[TBL] [Abstract][Full Text] [Related]
15. Cost-Effectiveness of Screening for Intermediate Age-Related Macular Degeneration during Diabetic Retinopathy Screening.
Chan CK; Gangwani RA; McGhee SM; Lian J; Wong DS
Ophthalmology; 2015 Nov; 122(11):2278-85. PubMed ID: 26315045
[TBL] [Abstract][Full Text] [Related]
16. Cost-utility analysis of screening for diabetic retinopathy in Japan: a probabilistic Markov modeling study.
Kawasaki R; Akune Y; Hiratsuka Y; Fukuhara S; Yamada M
Ophthalmic Epidemiol; 2015 Feb; 22(1):4-12. PubMed ID: 25517603
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of Evolocumab Therapy for Reducing Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease.
Fonarow GC; Keech AC; Pedersen TR; Giugliano RP; Sever PS; Lindgren P; van Hout B; Villa G; Qian Y; Somaratne R; Sabatine MS
JAMA Cardiol; 2017 Oct; 2(10):1069-1078. PubMed ID: 28832867
[TBL] [Abstract][Full Text] [Related]
18. Comparative effectiveness and cost-effectiveness of the implantable miniature telescope.
Brown GC; Brown MM; Lieske HB; Lieske PA; Brown KS; Lane SS
Ophthalmology; 2011 Sep; 118(9):1834-43. PubMed ID: 21723614
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
